Vioxx Viox Lawsuit Lawyer Heat Attack Vioxx Lawyer

  The first Vioxx trial against Merck & Co. is currently underway in
Texas. On July 28, 2005, the judge agreed to allow a pathologist
who autopsied Robert Ernst to testify to jurors. Although the original
autopsy in 2001 did not mention heart attack as a cause of death,
the pathologist has recently stated an irregular heartbeat was
brought on by a heart attack. This is a major blow to Merch & Co.
who are relying on the pathologist's original autopsy report.

     Merck & Co. withdrew Vioxx® from the marketplace on
September 30, 2004. According to the company, Vioxx® has been
linked to an increase of heart attacks and strokes in patients and
should be withdrawn.

     Many consumers taking Vioxx® have suffered strokes, heart
attacks, heart failure, chest pains, blood clots, serious bleeding
and even death. If you have taken Vioxx® and experienced any of
these health problems, call or email us immediately so that we can
evaluate your potential Vioxx claim. You can SUBMIT A SHORT AND
SIMPLE CASE EVALUATION HERE.

     The U.S. Food and Drug Administration (FDA) approved Vioxx®
in 1999 for the treatment of osteoarthritis and the management of
acute pain in adults. Vioxx®, a Cox-2 inhibitor used most often for
patients with osteoarthritis, has been linked by researchers to
serious side effects including an increase in the risk of blood clots;
severe intestinal damage, including ulcerations and bleeding;
heart attacks and strokes. In addition, meningitis was a side effect
involved in seven cases of patients taking Vioxx®.

     An article published in August 2001 in the Journal of the
American Medical Association raised concerns over the negative
side effects on cardiovascualar health related to both Vioxx® and
another COX-2 inhibitor Celebrex®.

     Likewise, a research report by the Institute for Clinical Evaluative
Science, published in the May 28, 2004 issue of The Lancet,
suggests that arthritis patients taking were 80% more likely to be
hospitalized for heart failure. This risk is compared to a 10% risk
with ibuprofen or naproxen, two non-steroidal anti-inflammatory
drugs. The researchers believe that until more research is done on
Vioxx®, doctors should use caution in prescribing Vioxx®, as well
as Celebrex®, to patients with heart disease.



	Vioxx Information